Department of Psychology, Faculty of Health Sciences, UIT The Arctic University of Norway, 9037, Tromsø, Norway.
Department of Child and Adolescent Psychiatry, Divisions of Child and Adolescent Health, University Hospital of North Norway, P.O. Box 19, 9038, Tromsø, Norway.
BMC Psychol. 2020 Mar 14;8(1):25. doi: 10.1186/s40359-020-0393-x.
This study aims to investigate effectiveness of a 6-week, transdiagnostic cognitive behavioral therapy (CBT) for anxiety and depression in adolescents, the Structured Material for Therapy (SMART), in naturalistic settings of child and adolescent mental health outpatient services (CAMHS).
A randomized controlled trial with waiting list control (WLC) was performed at three community CAMHS in Norway. Referred adolescents (N = 163, age = 15.72, 90.3% girls) scoring 6 or more on the emotional disorders subscale of the Strengths and Difficulties Questionnaire (SDQ) were randomly assigned to SMART or to WLC.
In the treatment group (CBT), 32.9% improved in the main outcome measure (SDQ), compared to 11.6% in the WLC. Clinically significant and reliable change was experienced by 17.7% in the CBT condition, compared to 5.8% in the WLC. No patients deteriorated. Statistically significant treatment effects were achieved for internalization symptoms, anxiety symptoms and general functioning.
These promising findings indicate that SMART may be considered as a first step in a stepped care model for anxiety and/or depression treatment in CAMHS. The recovery rates imply that further investigations into the effectiveness of brief treatments should be made. Furthermore, there is a need for more comprehensive second-stage treatments for some of these patients.
ClinicalTrials.gov Identifier: NCT02150265. First registered May 292,014.
本研究旨在探讨结构化治疗材料(SMART)在儿童和青少年心理健康门诊服务(CAMHS)的自然环境中,对青少年焦虑和抑郁的 6 周跨诊断认知行为疗法(CBT)的有效性。
在挪威的三个社区 CAMHS 进行了一项随机对照试验,设有等待名单对照(WLC)。被转诊的青少年(N=163,年龄=15.72 岁,90.3%为女孩)在优势与困难问卷(SDQ)的情绪障碍子量表上得分为 6 或更高,被随机分配到 SMART 组或 WLC 组。
在治疗组(CBT)中,主要结局测量(SDQ)中 32.9%的人得到改善,而 WLC 组中只有 11.6%的人得到改善。在 CBT 条件下,17.7%的人经历了临床显著和可靠的变化,而在 WLC 组中只有 5.8%的人经历了这种变化。没有患者恶化。在内部化症状、焦虑症状和一般功能方面,均达到了统计学显著的治疗效果。
这些有希望的发现表明,SMART 可以被考虑作为 CAMHS 中焦虑和/或抑郁治疗的阶梯式护理模型的第一步。恢复率表明,应该进一步研究简短治疗的有效性。此外,对于这些患者中的一些人,还需要更全面的第二阶段治疗。
ClinicalTrials.gov 标识符:NCT02150265。首次注册于 2014 年 5 月 29 日。